A Yale team of researchers led by noted Indian American oncologist Dr. Kiran Turaga has developed new national guidelines for ...

A new hydrogel-based platform to preserve live patient-derived tumor tissues in the lab could pave the way for faster, more ...

Researchers have developed a bioengineered hydrogel platform capable of preserving patient-derived tumor tissues for longer ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

This offers hope to some patients who face an average survival rate of just several months. Read more at straitstimes.com.

Prabhu A, Mishra D, Brandl A, Yonemura Y. Gastric cancer with peritoneal metastasis—A comprehensive review of current intraperitoneal treatment modalities. Front Oncol. (2022) 12:864647. doi: ...

We searched PubMed with no language restrictions for articles published up to July 1, 2024, using the search terms “gastric cancer”, “peritoneal”, “metastases”, and “prognosis”. This literature search ...

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 can improve survival in patients with gastric cancer and peritoneal metastasis, according to research presented at the ASCO ...

Findings A total of 4072 patients were included, of whom 1835 (45.1%) had peritoneal metastases. Of these, 58.1% had isolated peritoneal metastases. For patients with metastatic gastric cancer treated ...

Patients with gastric cancer peritoneal metastases (GCPM) often face an exceptionally grim prognosis, with severe symptoms and rapid disease progression. Median survival rates range from just three to ...

SINGAPORE: A recent breakthrough in gastric cancer research offers new hope to patients suffering from peritoneal metastasis, a condition associated with advanced stages of the disease.

Peritoneal metastasis of gastric cancer is mainly caused by the dispersion of free cancer cells from the serosal surface of the invaded stomach, from surgically transected lymphatic channels, and from ...